Teladoc Health Inc (NYSE:TDOC) Shares Bought by Commonwealth Equity Services LLC

Share on StockTwits

Commonwealth Equity Services LLC grew its holdings in shares of Teladoc Health Inc (NYSE:TDOC) by 8.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 33,826 shares of the health services provider’s stock after purchasing an additional 2,683 shares during the period. Commonwealth Equity Services LLC’s holdings in Teladoc Health were worth $2,290,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. CENTRAL TRUST Co increased its holdings in shares of Teladoc Health by 82.6% in the 2nd quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock worth $27,000 after acquiring an additional 171 shares during the period. Meridian Wealth Management LLC acquired a new stake in shares of Teladoc Health in the 2nd quarter worth about $27,000. Westside Investment Management Inc. acquired a new stake in shares of Teladoc Health in the 2nd quarter worth about $26,000. Capital Investment Advisory Services LLC increased its holdings in shares of Teladoc Health by 800.0% in the 3rd quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock worth $30,000 after acquiring an additional 400 shares during the period. Finally, Cornerstone Advisors Inc. increased its holdings in shares of Teladoc Health by 187.0% in the 2nd quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock worth $31,000 after acquiring an additional 303 shares during the period.

In other news, insider Lewis Levy sold 675 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $70.00, for a total transaction of $47,250.00. Following the completion of the transaction, the insider now owns 4,805 shares in the company, valued at approximately $336,350. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Andrew Turitz sold 9,158 shares of the firm’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $62.27, for a total transaction of $570,268.66. Following the transaction, the senior vice president now owns 6,827 shares of the company’s stock, valued at approximately $425,117.29. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 73,057 shares of company stock valued at $5,336,085. Insiders own 3.95% of the company’s stock.

A number of analysts recently weighed in on TDOC shares. ValuEngine raised shares of Teladoc Health from a “buy” rating to a “strong-buy” rating in a report on Tuesday, October 22nd. Credit Suisse Group increased their price objective on shares of Teladoc Health from $67.00 to $76.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Craig Hallum increased their price objective on shares of Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Piper Jaffray Companies set a $87.00 price objective on shares of Teladoc Health and gave the stock a “buy” rating in a report on Friday, August 16th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Teladoc Health from $82.00 to $83.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Three equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Teladoc Health currently has a consensus rating of “Buy” and a consensus target price of $77.43.

Teladoc Health stock opened at $80.66 on Monday. The stock has a market cap of $5.69 billion, a price-to-earnings ratio of -56.01 and a beta of 1.39. The company has a current ratio of 6.55, a quick ratio of 6.55 and a debt-to-equity ratio of 0.44. The company’s 50-day moving average price is $70.47 and its two-hundred day moving average price is $64.55. Teladoc Health Inc has a 52 week low of $42.08 and a 52 week high of $82.86.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.28) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.40) by $0.12. Teladoc Health had a negative net margin of 20.15% and a negative return on equity of 11.23%. The firm had revenue of $137.96 million for the quarter, compared to analysts’ expectations of $136.46 million. During the same quarter last year, the company earned ($0.34) EPS. Teladoc Health’s quarterly revenue was up 24.3% on a year-over-year basis. Research analysts expect that Teladoc Health Inc will post -1.43 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: Are we seeing the beginning of a new bubble?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Fortive  Upgraded by Citigroup to Buy
Fortive Upgraded by Citigroup to Buy
Camden Property Trust  Given New $118.00 Price Target at Deutsche Bank
Camden Property Trust Given New $118.00 Price Target at Deutsche Bank
Boardwalk REIT  Hits New 52-Week High at $49.04
Boardwalk REIT Hits New 52-Week High at $49.04
Qutoutiao  Reaches New 1-Year Low at $2.56
Qutoutiao Reaches New 1-Year Low at $2.56
Westhaven Ventures  Shares Up 7.2%
Westhaven Ventures Shares Up 7.2%
Zilliqa Reaches One Day Volume of $14.88 Million
Zilliqa Reaches One Day Volume of $14.88 Million


© 2006-2019 Ticker Report